India: Product Patenting in the Indian Pharma Sector

Last Updated: 14 June 2006
Article by Manisha Singh Nair

In the recent times the Indian pharma sector has been marked by dynamic changes. The Patent Act of 1970 as amended on March 22, 2005 marked the end of a protected era and has brought in a new phase in the integration of India into the global pharmaceutical market. The new amendment further makes copying of post-1995 patented drugs illegal. At the same time the amendment granting product patents has been hailed to be opening vast opportunities to the Indian Pharmaceutical firms. A look at the sector shows that large companies like Ranbaxy, Nicholas Piramal, Dr Reddy's, Wockhardt, Lupin etc, have been investing heavily in R&D and are planning to launch their own-patented molecules all over the world. Wockhardt in order to bring innovative and advanced drugs in speciality areas to India, has signed an in-licensing agreement with Life Sciences Investment Limited (LSI), a UK based company, to market and produce Vitrix, a patented product for the treatment of vitiligo, a pigmentation disorder for which the active pharmaceutical ingredients shall be imported from LSI .

As India enters product patent regime the impact of such a move would definitely have on the Indian pharmaceutical industry, health care industry etc., and therefore the legal machinery enforcing these regulations demands attention. In the pharma sector today, according to studies, India produces 22% of the global generic market. It can be said that in the last decade, after liberalization, Indian industry has focused on the world market and brought about structural and fundamental changes, like investing in research and accessing global market.

The regulatory system focused mainly on process patents has helped to establish the foundation of a strong and highly competitive domestic pharmaceutical industry along with helping it to emerge into a world supplier of bulk drugs and medicines at affordable prices not only to common man in India and the developing world. Admittedly it cannot be overlooked that the introduction of product patents will, however bring forth significant changes and divides within the industry. It cannot be denied that the process patent helped the Indian Pharmaceutical Industry to flourish into a world-class generics industry but the product patent regime would turn out to be more favorable to players with built-in scientific and technical resources.

In this context a recent decision by the High Court of Madras can be discussed. In Wockhardt Ltd. v. Hetero Drugs Ltd. & Ors 2006 (32) PTC 65 (Mad.) (DB), the appellant was the holder of Process patent, Exclusive Marketing Rights and Drug License for the manufacture of pharmaceutical preparation namely, Nadifloxacin 1% cream. The first respondent had started manufacturing and selling the same product infringing the patent and EMR granted to the appellant. Appellant was already holding the Process Patent for an admixture compound. By 2002, the Appellant made an application for Product Patent, which was treated as a mail box application. In the mean time, the first respondent applied for manufacturing license to manufacture Nadifloxacin 1% cream by adopting US Patent 1981 and Japan Patent 1983 under the trademark Nadiderm. In 2004 the Drugs Controller General granted license to the respondents and they started manufacturing and selling Nadifloxacin 1% cream. The question arose as to who could be the manufacturer and as to whether the appellant in this case could claim exclusive right over the EMR and the process patent. According to the respondents, the appellants could not claim invention of the product, since the first respondent obtained manufacturing license for the impugned product from the Drug Controller General. As a regular marketing license of a drug is to be preceded by a trial-manufacturing license for the purpose of clinical trial, the first respondent had been manufacturing the impugned product prior to 2004 itself. Moreover the first respondent contended that they had followed only the process adopted by the US and Japanese Patents and hence, as such the appellants could not claim EMR and the Process Patent.

The court observed that the Patent Office had granted both Process Patent and EMR in favour of the appellant. The appellants had obtained Process Patent with effect from the date of application in 2000 and the appellant had also applied for Product Patent after the amendment of the Act. Further it held that EMR being a short-term arrangement the appellant would suffer irreparable damage because of elapse of that period. It granted injunction in favour of the appellant, thus granting protection to the appellant’s exclusive rights for its product, the Nadifloxacin 1% cream. The case thereby proves the liberal approach and the bent of mind of the court towards products patent.

© Lex Orbis 2006

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.